Cellegy Pharmaceuticals Inc., of Novato, Calif., appointed John Farato the board of directors.Diatech Inc., of Londonderry, N.H., named Mark Attarian chieffinancial officer.Gen-Probe Inc., of San Diego, appointed Naoya Saishu chiefoperating officer.Genetics Institute Inc., of Cambridge, Mass., appointed Karen Dawesvice president of marketing.InflaZyme Pharmaceuticals Ltd., of Vancouver, British Columbia,appointed Norman Wong director of finance.MedImmune Inc., of Gaithersburg, Md., appointed BogdanDziurzynski senior vice president of regulatory affairs and qualityassurance.Millennium Pharmaceuticals Inc., of Cambridge, Mass., named StevenHoltzman, chief business officer; Frank Lee, vice president ofresearch; Geoffrey Duyk, director of genomics; and Robert Tepper,director of biology.Neurogen Corp., of Branford, Conn., appointed Stephen Davis vicepresident of finance, chief financial officer and treasurer.OxiGENE Inc., of New York, named Hans Wigzell chairman of itsinternational scientific advisory board.Paracelsian Inc., of Ithaca, N.Y., named Keith Rhodes actingpresident, chief executive officer and chairman.Symphony Pharmaceuticals Inc., of Malvern, Pa., appointed DuncanTaylor director of pharmacology.

(c) 1997 American Health Consultants. All rights reserved.